Technology | June 18, 2009

FDA Approves St. Jude's Cool Point Irrigation Pump for RF Ablations

June 18, 2009 - St. Jude Medical Inc. said today the FDA approved its Cool Point Irrigation Pump, used in conjunction with St. Jude Medical (SJM) open-irrigated ablation catheters, to supply a continuous flow of saline through the catheter’s inner lumen to cool the ablation electrode for more effective energy delivery.

Designed to enhance physicians’ abilities to perform successful atrial ablations, the new Cool Point Irrigation Pump was developed specifically for use with the company’s IBI-1500T9-CP cardiac ablation generator and family of Therapy Cool Path irrigated catheters.

The Cool Point Irrigation Pump also provides monitoring and safety features designed to give physicians more control over therapy delivery, the company said. Physicians can monitor the total volume of irrigation solution delivered through an easy-to-read display.

The pump’s proprietary tubing includes an in-line occlusion detector, which monitors flow pressure between the pump and the catheter tip, providing an alert if flow pressure increases substantially relative to the flow rate. In addition, the pump has redundant bubble detectors, each designed to detect bubbles as small as 2 microliters.

For more information: www.sjm.com


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now